(Total Views: 568)
Posted On: 05/08/2020 2:49:41 PM
Post# of 154011
I predicted this a week ago:
Quote:
I anticipate that the FDA will next grant Gilead a 2-week combo trial with remdesivir and an anti-inflamatory, since CytoDyn has apparently rejected being involved.
And, I anticipate the FDA will quickly rubber stamp an approval. It's clear from Fauci's statements that this is the direction they are going.
Read More: https://investorshangout.com/post/view?id=575...z6LsUJO3lK
(1)
(0)
